Rebif Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

BIIB017 (PEGylated Interferon Beta-1a) Related Flu-Like Symptoms in Relapsing Multiple Sclerosis Participants
Condition:   Relapsing-Remitting Multiple SclerosisInterventions:   Drug: BIIB017 (Peginterferon beta-1a);   Drug: NaproxenSponsor:   Biogen IdecRecruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2013 Category: Research Source Type: clinical trials

BIIB017 (PEGylated Interferon Beta-1a) Related Flu-Like Symptoms in Relapsing Multiple Sclerosis Participants
Condition:   Relapsing-Remitting Multiple SclerosisInterventions:   Drug: BIIB017 (Peginterferon beta-1a);   Drug: NaproxenSponsor:   Biogen IdecActive, not recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2013 Category: Research Source Type: clinical trials

BIIB017 (PEGylated Interferon Beta-1a) Related Flu-Like Symptoms in Relapsing Multiple Sclerosis Participants
Condition:   Relapsing-Remitting Multiple SclerosisInterventions:   Drug: BIIB017 (Peginterferon beta-1a);   Drug: NaproxenSponsor:   Biogen IdecRecruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2013 Category: Research Source Type: clinical trials

Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex
Condition:   Multiple SclerosisInterventions:   Drug: BIIB033;   Other: Placebo;   Drug: Interferon Beta-1aSponsor:   Biogen IdecActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2013 Category: Research Source Type: clinical trials